Home > Insider Trading > Filing (0001179110-18-002291)

Filing Details

Accession Number:: 0001179110-18-002291
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-16 17:10:19
Reporting Period:: 2018-02-14

Accepted Time:: 2018-02-16 17:10:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1578845	Allergan Plc	AGN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1536778	William Meury	Clonshaugh Business And Technology Park, Coolock, Co. Dublin L2 D17 E400	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares, Par Value $0.0001	Acquisiton	2018-02-14	1,957	$51.07	56,944	No	4	M	Direct
Ordinary Shares, Par Value $0.0001	Acquisiton	2018-02-14	2,765	$51.07	59,709	No	4	M	Direct
Ordinary Shares, Par Value $0.0001	Acquisiton	2018-02-14	1,510	$66.20	61,219	No	4	M	Direct
Ordinary Shares, Par Value $0.0001	Acquisiton	2018-02-14	17,381	$66.20	78,600	No	4	M	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2018-02-14	25,079	$157.18	53,521	No	4	S	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2018-02-14	1,200	$157.60	52,321	No	4	S	Direct
Ordinary Shares, Par Vaule $0.0001	Disposition	2018-02-14	1,700	$158.78	50,621	No	4	S	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2018-02-14	2,400	$159.82	48,221	No	4	S	Direct
Ordinary Shares, Par Vaule $0.0001	Disposition	2018-02-14	1,000	$161.10	47,221	No	4	S	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2018-02-14	4,700	$162.22	42,521	No	4	S	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2018-02-14	7,200	$163.04	35,321	No	4	S	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2018-02-14	2,000	$164.62	33,321	No	4	S	Direct
Ordinary Shares, Par Value $0.0001	Disposition	2018-02-14	13,600	$165.16	19,721	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Incentive Stock Option	Disposition	2018-02-14	1,957	$0.00	1,957	$51.07
Ordinary Shares	Non-Qualified Options to Purchase Common Stock	Disposition	2018-02-14	2,765	$0.00	2,765	$51.07
Ordinary Shares	Incentive Stock Option	Disposition	2018-02-14	1,510	$0.00	1,510	$66.20
Ordinary Shares	Non-Qualified Options to Purchase Common Stock	Disposition	2018-02-14	17,381	$0.00	17,381	$66.20

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2018-12-07	No	4	M	Direct
2018-12-07	No	4	M	Direct
2019-12-06	No	4	M	Direct
2019-12-06	No	4	M	Direct

Footnotes

The total number of shares reported has been reduced by 423 due to prior inadvertent over-reporting of shares beneficially owned by the Reporting Person.
Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.29 to $157.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.30 to $158.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.30 to $159.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.41 to $160.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.59 to $161.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.67 to $162.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.68 to $163.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.04 to $165.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.05 to $165.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The option vested on December 8, 2013.
The option vested in five equal installments on December 8, 2009, 2010, 2011, 2012 and 2013.
The option vested on December 7, 2014.
The option vested in five equal installments on December 7, 2010, 2011, 2012, 2013 and 2014.